Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Dlugi, Theresa A.
22  Ergebnisse:
Personensuche X
?
1

A mass spectrometry assay for detection of endogenous and l..:

Wang, Xuejun ; McKillop, William M. ; Dlugi, Theresa A....
The Journal of Gene Medicine.  26 (2023)  1 - p. , 2023
Link: https://doi.org/10.1002/..
 
?
2

Pathophysiological characterization of the Townes mouse mod..:

Alvarez-Argote, Juliana ; Dlugi, Theresa A. ; Sundararajan, Teresa...
Translational Research.  254 (2023)  - p. 77-91 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Novel anti-CD30/CD3 bispecific antibodies activate human T ..:

Faber, Mary L. ; Oldham, Robyn A. A. ; Thakur, Archana...
Frontiers in Immunology.  14 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
4

Endocytosis of the thrombopoietin receptor Mpl regulates me..:

Eaton, Nathan ; Boyd, Emily K. ; Biswas, Ratnashree...
Frontiers in Oncology.  12 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
5

Novel anti-CD30/CD3 bispecific antibodies activate human T ..:

Faber, Mary L ; Oldham, Robyn A. A ; Thakur, Archana...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461807/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
6

Endocytosis of the thrombopoietin receptor Mpl regulates me..:

Eaton, Nathan ; Boyd, Emily K ; Biswas, Ratnashree...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468709/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
7

Image_7_Novel anti-CD30/CD3 bispecific antibodies activate ..:

Mary L. Faber ; Robyn A. A. Oldham ; Archana Thakur...
doi:10.3389/fimmu.2023.1225610.s007.  , 2023
Link: https://doi.org/10.3389/..
 
?
8

Novel anti-CD30/CD3 bispecific antibodies activate human T ..:

Mary L. Faber ; Robyn A. A. Oldham ; Archana Thakur...
https://www.frontiersin.org/articles/10.3389/fimmu.2023.1225610/full.  , 2023
Link: https://doi.org/10.3389/..
 
?
9

Image_5_Novel anti-CD30/CD3 bispecific antibodies activate ..:

Mary L. Faber ; Robyn A. A. Oldham ; Archana Thakur...
doi:10.3389/fimmu.2023.1225610.s005.  , 2023
Link: https://doi.org/10.3389/..
 
?
10

Image_2_Novel anti-CD30/CD3 bispecific antibodies activate ..:

Mary L. Faber ; Robyn A. A. Oldham ; Archana Thakur...
doi:10.3389/fimmu.2023.1225610.s002.  , 2023
Link: https://doi.org/10.3389/..
 
?
11

Image_3_Novel anti-CD30/CD3 bispecific antibodies activate ..:

Mary L. Faber ; Robyn A. A. Oldham ; Archana Thakur...
doi:10.3389/fimmu.2023.1225610.s003.  , 2023
Link: https://doi.org/10.3389/..
 
?
12

Image_1_Novel anti-CD30/CD3 bispecific antibodies activate ..:

Mary L. Faber ; Robyn A. A. Oldham ; Archana Thakur...
doi:10.3389/fimmu.2023.1225610.s001.  , 2023
Link: https://doi.org/10.3389/..
 
?
13

Image_8_Novel anti-CD30/CD3 bispecific antibodies activate ..:

Mary L. Faber ; Robyn A. A. Oldham ; Archana Thakur...
doi:10.3389/fimmu.2023.1225610.s008.  , 2023
Link: https://doi.org/10.3389/..
 
?
14

Table_2_Novel anti-CD30/CD3 bispecific antibodies activate ..:

Mary L. Faber ; Robyn A. A. Oldham ; Archana Thakur...
doi:10.3389/fimmu.2023.1225610.s010.  , 2023
Link: https://doi.org/10.3389/..
 
?
15

Image_4_Novel anti-CD30/CD3 bispecific antibodies activate ..:

Mary L. Faber ; Robyn A. A. Oldham ; Archana Thakur...
doi:10.3389/fimmu.2023.1225610.s004.  , 2023
Link: https://doi.org/10.3389/..
 
1-15